Cardiac Resynchronization Therapy Market Worth $5.1 Billion by 2024 - Exclusive Report by MarketsandMarkets

CHICAGO, April 17, 2019 /PRNewswire/ -- According to the new market research report "Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024", published by MarketsandMarkets, the Cardiac Resynchronization Therapy (CRT) Market is projected to reach USD 5.1 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 4.4%.

Don't miss out on business opportunities in Cardiac Resynchronization Therapy Market

The growth of the CRT systems market is mainly driven by the increasing incidence of target disease and growth in the geriatric population. Rising investments and support, along with technological advancements, are also contributing to the growth of the market.

By product type, the cardiac resynchronization therapy defibrillators (CRT-Ds) segment accounted for the largest share market in 2018

On the basis of product type, the CRT market is segmented into cardiac resynchronization therapy defibrillators (CRT-Ds) and cardiac resynchronization therapy pacemakers (CRT-Ps). The CRT-Ds segment accounted for the largest share of the market in 2018. This is majorly attributed to the increasing acceptance of CRT-Ds over pacemakers and the launch of technologically advanced devices. Furthermore, growth in this market segment is largely driven by the increasing incidence of target diseases.

Browse in-depth TOC on "Cardiac Resynchronization Therapy Market"

59 – Tables

27 – Figures  

107 – Pages  

Get 10% Free Customization on this Report: 

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=194506584

In 2018, the hospitals & cardiac centers segment dominated the CRT market

On the basis of end user, the market is segmented into hospitals & cardiac centers and ambulatory surgery centers. Hospitals & cardiac centers accounted for the largest share of the market in 2018. The increasing prevalence of CVD, rising number of surgical procedures performed, favorable reimbursement scenario, and the increasing number of critical care and intensive care units are some of the key factors driving the growth of the hospitals & cardiac centers segment.